OVARIAN CANCER

Many female menstrual disorder is often encountered problems, including extending or shortening cycle, increased amount of bleeding, these belong to dysfunctional bleeding, referred to as DUB.

Women of childbearing age are generally more because luteal function well, resulting in menstrual disorders, which means although cycle, but the cycle will shorten, or more menstrual bleeding. Some 20 days to the first menstruation, it is because luteal function well. Similarly some may last 30 days, but rather a long time hemorrhage, which is bad because luteal function caused. While these cases more, but the problem is not very serious and <BR>, relatively speaking, not a great amount of bleeding.

Tags: age, bleeding, cancer, cases, cause, cyst, cystic, days, eat, ert, gene, grams, gynecological, increased, ovarian, ovary, polycystic, syndrome, tea, time, treatment, women

Denmark Gronloud such report, as paclitaxel plus platinum chemotherapy after complete remission in patients with ovarian cancer, if recurrence of a solitary lesion again cytoreductive surgery may improve survival. (Eur J Surg Oncol 2005,31:67)

In the retrospective study selected criteria: 1 Guide to the residual initial stage operation and confirmed by histological examination of epithelial ovarian cancer; (2) complete remission after first-line treatment; 3. Imaging confirmed pots peritoneal metastasis; (4) Surgical resection of lesions for the purpose.

Tags: age, cancer, cases, cell, chemotherapy, eat, examination, metastasis, ovarian, paclitaxel, patients, rate, resection, residual, study, surgery, surgical, survival, therapy, time, treatment, tumor, tumors

In recent decades, the treatment of gynecologic cancer progress has been made, but only the ovarian cancer there is no significant improvement. The incidence of ovarian cancer Habitat Gynecologic Oncology third, but it was the first fatality rate. Its cause high mortality due to the growth of ovarian cancer site concealment, not be seen directly, patients still in the early stages of the lack of simple and practical method of diagnosis. Most (about 70%) have been newly diagnosed patients with peritoneal metastasis pots. Currently taken by surgery, radiotherapy, chemotherapy and immunotherapy for the treatment of Chinese medicine integrated with the right therapy, in the treatment of advanced worse still, it is difficult to avoid recurrence. But by early diagnosis and treatment of patients with ovarian cancer prognosis is quite different. Case in epithelial ovarian cancer, according to statistics, the five-year survival rate, 80% for stage I, 40% for Stage II; While Ⅲ period just below 5%. Visibility early detection, early diagnosis and treatment of patients with ovarian cancer is a lifetime event.

Tags: abdominal, age, annex, anti, bleeding, cancer, carcinoma, cases, cause, chemotherapy, clinical, cyst, cystic, diagnosis, diet, early, eat, ert, examination, family, fat, growth, gynecological, history, incidence, increased, life, malignant, mass, metastasis, method, oppression, ovarian, pain, patients, pelvic, poor, prognosis, protein, quality, radiotherapy, rate, reduce, resection, surface, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors, women

Abdominal mass
Medium large following abdominal tumor, without complications or malignant, its greatest feature is movable, can often move from abdominal pelvic push.
Mass General of tenderness, but in case of complications or malignant transformation, tumor itself is not only tenderness, and even stimulate peritoneal symptoms.

Levy ascites
There often ascites tumor characteristics, such as benign ovarian cyst and fibroid may produce ascites papillary cystadenoma. Endocrine symptoms such as hair, voice role the extra change, as the masculine clitoral hypertrophy cyst.

Cachexia
It is characterized by extreme abdominal swelling, significant weight loss, painful facial expressions and serious diseases.

Tags: abdominal, benign, clinical, cyst, eat, ert, gene, malignant, mass, ovarian, pain, pelvic, symptoms, tumor

Treatment of ovarian cancer is still surgery and chemotherapy, although postoperative adjuvant systemic chemotherapy has been the effect certainly, but in some patients because of poor health and not systemic tolerance of the boil, and in some patients for fear of adverse reactions of chemotherapy automatically abandon further treatment, which greatly affects the quality of life and survival rate , an increase of ovarian cancer recurrence possible. The TCM adjuvant treatment of patients with chemotherapy can improve and the tolerance level of immunity and, therefore, Chinese medicine treatment of ovarian cancer has been more and more attention.

Tags: age, bleeding, cancer, cause, chemotherapy, cisplatin, clinical, drug, drugs, eat, ert, gene, injection, intravenous, knowledge, life, ovarian, patients, poor, prognosis, quality, rate, second, surgery, survival, symptoms, therapy, time, treatment, tumor, tumors

Serous cystadenoma
Zhu serous tumor of the kidney from the body cavity epithelium, is the most common tumors of the ovary. According to national statistics, the total of 2007-09-07 16:00:00.1% of ovarian tumors common in women aged 30-40. The unilateral nature, but there are also many of the bilateral. Simple solution can be divided into gland capsule and two papillary serous cystadenoma.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, breast, cancer, carcinoma, cases, cause, cell, cells, children, clinical, cyst, cystic, cysts, diagnosis, early, eat, ert, estrogen, gene, group, groups, growth, incidence, increased, malignant, mass, metastasis, metastatic, oppression, ovarian, ovary, patients, pelvic, poor, prognosis, protein, quality, radiation, rate, resection, surface, surgery, surgical, survival, symptoms, time, treatment, tumor, tumors, usually, uterine, women

A concept
Ovarian cysts are generalized on an ovarian tumor, all ages are sick, but the most aged 20-50. The prevalence of ovarian cancer rarely sick, so early diagnosis difficult, attendance at the 70% already advanced, little access to early treatment, five-year survival rate always hovering in the 20-30%, the threat to women's lives one of the most serious cancer, ovarian is smaller organ in the human body but for a good variety of tumor site, ovarian cancer can have a variety of nature and form - a single - or mixed type, or of the bilateral side, cystic or substantive, benign or malignant, and many women have ovarian tumors or male sex hormones.

Tags: abdominal, age, anti, benign, bleeding, body, cancer, cause, clinical, cyst, cystic, cysts, diagnosis, early, eat, eggs, ert, examination, gene, growth, gynecological, increased, malignant, mass, oppression, ovarian, pain, patients, pelvic, rate, second, survival, symptoms, treatment, tumor, tumors, usually, women

Daqing City in Heilongjiang hospital recently adopted a new therapy combining traditional Chinese and western medicine, ultrasound-guided puncture, self-developed "Gallnut hardening agent" for the treatment of ovarian cysts, to date a total of more than 400 patients is associated disarmed.

"Gallnut hardening agent" by gallnut, brucea javanica, Yuan Hu, the group formed by the injection of a scientific process. Modern pharmacology studies confirmed: Gallnut obvious convergence, enable protein containing tannic acid precipitation; Brucea javanica contained Brucea javanica oil, could undermine something superfluous cell nucleus; Yuan Hu good analgesic effect.

Tags: age, cell, cells, cyst, cysts, drug, eat, group, injection, ovarian, patients, protein, therapy, treatment

Ovarian cancer

Tags: abdominal, body, cancer, cause, cell, cells, eat, eggs, ert, examination, grams, history, incidence, life, ovarian, pain, patients, pelvic, powder, reduce, risk, surface, tea, time, treatment, women

Ovarian cancer is the worst prognosis of gynecologic tumors. Patients with advanced epithelial ovarian cancer five-year survival rates generally below 30%, mainly in patients with relapsing most (about 75%), relapse after chemotherapy to poor results.

For the treatment of recurrent ovarian cancer chemotherapy drugs many, no less than 10 species, but only clinical remission rate of 20% to 30%, no progress median survival time (PFS) for 2 to 6 months, the median overall survival (OS) for six to 12 months. Therefore, to improve the efficacy of chemotherapy drugs delay, but the development of new drugs is very difficult, efficient use of existing drugs is an effective way to <BR>.

Tags: cancer, cases, chemotherapy, cisplatin, clinical, drug, drugs, early, eat, exploration, gene, group, method, ovarian, p53, paclitaxel, patients, pmtc, poor, positive, prognosis, rate, second, study, survival, taxol, therapy, time, treatment, tumor, tumors